We are live on ! Find out more
JHP

James Hambro & Partners Portfolio holdings

AUM $2.76B
1-Year Est. Return 19.67%
This Fund
S&P 500
This Quarter Est. Return
+10.84%
1 Year Est. Return
+19.67%
3 Year Est. Return
+79.16%
5 Year Est. Return
+89.36%
10 Year Est. Return
AUM
$2.14B
AUM Growth
+$258M
Cap. Flow
+$61.4M
Cap. Flow %
2.88%
Top 10 Hldgs %
57.68%
Holding
55
New
3
Increased
27
Reduced
15
Closed
3

Top Buys

Rank Stock Value
1
SNPS icon
Synopsys
SNPS
+$38.7M
2
KO icon
Coca-Cola
KO
+$8.59M
3
UNH icon
UnitedHealth
UNH
+$7.13M
4
POOL icon
Pool Corp
POOL
+$6.97M
5
DHR icon
Danaher
DHR
+$5.48M

Top Sells

Rank Stock Value
1
TSM icon
TSMC
TSM
+$32.1M
2
MSFT icon
Microsoft
MSFT
+$3.96M
3
GLD icon
SPDR Gold Trust
GLD
+$1.13M
4
ACN icon
Accenture
ACN
+$585K
5
INTU icon
Intuit
INTU
+$447K

Sector Composition

Rank Sector Weight
1 Financials 26.04%
2 Technology 22%
3 Healthcare 17.6%
4 Consumer Discretionary 8.51%
5 Industrials 8.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JPM icon
1
JPMorgan Chase
JPM
$935B
$152M 7.13%
760,422
-1,680
-0.2% -$303K
MSFT icon
2
Microsoft
MSFT
$3.45T
$149M 6.99%
355,708
-9,785
-3% -$3.96M
GOOG icon
3
Alphabet (Google) Class C
GOOG
$4.36T
$132M 6.16%
864,134
+8,577
+1% +$1.24M
LIN icon
4
Linde
LIN
$221B
$126M 5.92%
272,403
+3,227
+1% +$1.4M
V icon
5
Visa
V
$684B
$122M 5.71%
437,968
+8,392
+2% +$2.32M
APH icon
6
Amphenol
APH
$198B
$121M 5.68%
2,104,046
+8,566
+0.4% +$449K
TMO icon
7
Thermo Fisher Scientific
TMO
$213B
$112M 5.25%
192,964
+5,071
+3% +$2.85M
PGR icon
8
Progressive
PGR
$123B
$111M 5.18%
534,698
+116
+0% +$21.5K
AMZN icon
9
Amazon
AMZN
$2.92T
$104M 4.88%
577,892
+27,365
+5% +$4.57M
UNH icon
10
UnitedHealth
UNH
$376B
$102M 4.79%
206,745
+14,019
+7% +$7.13M
ISRG icon
11
Intuitive Surgical
ISRG
$127B
$95.5M 4.47%
239,445
+3,628
+2% +$1.37M
SPGI icon
12
S&P Global
SPGI
$121B
$84.7M 3.96%
199,324
+11,362
+6% +$4.92M
TXN icon
13
Texas Instruments
TXN
$252B
$83.7M 3.92%
480,658
+32,193
+7% +$5.37M
POOL icon
14
Pool Corp
POOL
$6.75B
$83.6M 3.91%
207,307
+17,828
+9% +$6.97M
AON icon
15
Aon
AON
$76.5B
$79.9M 3.74%
239,360
+15,495
+7% +$4.8M
UNP icon
16
Union Pacific
UNP
$174B
$78.6M 3.68%
319,598
+11,387
+4% +$2.8M
TJX icon
17
TJX Companies
TJX
$174B
$77.1M 3.61%
761,108
+16,601
+2% +$1.61M
KO icon
18
Coca-Cola
KO
$377B
$70.9M 3.32%
1,158,948
+143,017
+14% +$8.59M
DHR icon
19
Danaher
DHR
$137B
$62.5M 2.93%
250,443
+22,438
+10% +$5.48M
TSM icon
20
TSMC
TSM
$2.1T
$56.1M 2.63%
412,442
-258,695
-39% -$32.1M
SNPS icon
21
Synopsys
SNPS
$74.4B
$40.1M 1.88%
+70,268
New +$38.7M
GLD icon
22
SPDR Gold Trust
GLD
$131B
$18.8M 0.88%
91,268
-5,881
-6% -$1.13M
NOC icon
23
Northrop Grumman
NOC
$77.1B
$17.5M 0.82%
36,674
-412
-1% -$190K
IBM icon
24
IBM
IBM
$211B
$15.1M 0.71%
78,990
+4,286
+6% +$782K
IRM icon
25
Iron Mountain
IRM
$36.4B
$9.89M 0.46%
123,390
-5,230
-4% -$379K

Similar funds

James Hambro & Partners's Q1 2024 Portfolio in Review

As of Q1 2024, James Hambro & Partners held 55 positions worth $2.14B, up 14% from $1.88B the previous quarter. Its ten largest holdings account for 58% of the portfolio.

James Hambro & Partners's Q1 2024 filing shows 3 new, 27 increased, 15 reduced and 3 closed positions. Its largest new stake was Synopsys: 70,268 shares worth $40.1M. The largest sale was TSMC, an estimated $32.1M.

By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 26% a quarter earlier, followed by Technology and Healthcare.

  • James Hambro & Partners's largest Q1 2024 buy was Synopsys: 70,268 shares worth $40.1M.
  • James Hambro & Partners added most to Coca-Cola in Q1 2024, an estimated $8.59M increase.
  • James Hambro & Partners's biggest Q1 2024 reduction was TSMC, cutting an estimated $32.1M.
  • James Hambro & Partners fully exited Estee Lauder in Q1 2024, selling an estimated $304K.
  • James Hambro & Partners's ten largest holdings make up 58% of its $2.14B portfolio in Q1 2024.
  • James Hambro & Partners opened 3 new positions and closed 3 in Q1 2024.
  • James Hambro & Partners's portfolio value rose 14% quarter-over-quarter to $2.14B.

Based on James Hambro & Partners's 13F filing for Q1 2024, filed 26 Apr 2024.